Conversation

Notices

1. Flipboard Science Desk (sciencedesk@flipboard.social)'s status on Thursday, 18-Apr-2024 23:02:02 JST Flipboard Science Desk

   • Knowable Magazine

   Few drugs have achieved the stardom that semaglutide, marketed in the United States as Ozempic or Wegovy, has today.

   @KnowableMag explores what’s next in the Ozempic era: https://flip.it/0FVji6

   Story also available in Spanish: https://es.knowablemagazine.org/content/articulo/salud-enfermedades/2024/que-sigue-en-la-era-ozempic

   #Ozempic #Drugs #Health #WeightLoss #Pharmaceuticals #Medicine

   • Flipboard Science Desk (sciencedesk@flipboard.social)'s status on Friday, 19-Apr-2024 09:14:27 JST Flipboard Science Desk

     in reply to

     • Stan Wonn 🏳️‍🌈 🌹
     • Knowable Magazine

     @StanWonn @KnowableMag Thanks for sharing your story. It's important to remember that these drugs aren't just for vanity-inspired weight loss.

   • Stan Wonn 🏳️‍🌈 🌹 (stanwonn@mstdn.social)'s status on Friday, 19-Apr-2024 09:14:28 JST Stan Wonn 🏳️‍🌈 🌹

     in reply to

     • Knowable Magazine

     @ScienceDesk @KnowableMag As someone who is a diabetic, I have been on Mounjaro and it has been a game-changer for me. However, I am constantly having to shift dosages or go to less effective medications because the manufacturers are not keeping up with the demand for the product. I would like to think that they'd prioritize diabetics but instead they clearly are chasing profitability as their top priority. But that's capitalism in a nut shell for you.